Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)
ID Number 11-0004Principal Investigator(s)
Dan V Iosifescu
Department(s) or Division(s)
The purpose of this study is to look at the efficacy and safety of Low Field Magnetic Stimulation (LFMS) as a rapid antidepressant treatment for patients with hard to treat depression who are currently on an antidepressant medication that is working for them. In past trials, treatment with LFMS has had positive effects on mood. The Food and Drug Administration (FDA) considers LFMS an investigational device with Non Significant Risk, and is therefore safe to be used in clinical trials. However, the LFMS device is not approved for the treatment of major depressive disorder and is considered an experimental treatment in this study.
One may qualify to take part in this research study if s/he has been diagnosed with major depressive disorder (MDD) and has not responded to past treatments. Participation in this study is expected to last about 5 weeks. Eligible participants will receive treatment at no cost and compensation for their time.
Recruiting Patients: Yes